Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
about
Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disordersBig data for big questions: it is time for data analysts to actCerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson's disease: a cross-sectional study.Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease.A meta-analysis of cerebrospinal fluid visinin-like protein-1 in alzheimers disease patients relative to healthy controls and mild cognitive impairment patients.A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury.Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders.A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.Classification of MRI and psychological testing data based on support vector machine.In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
P2860
Q26741861-6C535F11-33E7-49E2-B107-7E216723625EQ28554784-47BA9E11-C046-4ED1-B326-79691E78D076Q33587212-BB432124-CDB3-4888-B55D-2C72F7B58447Q33917300-49B18955-CD33-453D-BFEB-59FE3966CF53Q36189198-DBBBC779-A7C7-4970-B257-4D1D99584738Q36885492-BEADB625-911C-4FC7-884D-6C3827FAB90FQ37297626-0BBAAD28-F4F0-4D84-8395-0A0C8C9BDF63Q37627051-C14A723F-93A2-4F5C-A3CC-EA9DBDBDC90AQ38683919-D0752ACC-8011-4115-A910-818932140D03Q38704916-5E58E722-8091-423B-87F2-0AB3B3261DCEQ38814839-3090483B-E0D9-4E0F-B21A-50A0A8198C7AQ46003126-E9F525FD-4FC3-46D4-83CD-3BA6DA55B136Q47141209-DB8615EE-935A-423A-B8D8-6BEAE21EA5AFQ47250022-AFEBC80B-C0D7-4BD8-AC1D-BC657CEC12C1Q47708649-97056840-AD94-48A4-A978-5EA0918DCC84Q47833026-F16CFB47-0729-4509-AF30-DEC89EBFF764Q50334465-5D312BBE-C86A-4DA7-9CD7-BA881A1957C7Q58693324-773A18CC-F980-4CF0-AC3E-242F5C3640A4
P2860
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cerebrospinal Fluid Markers of ...... hy in Early Alzheimer Disease.
@ast
Cerebrospinal Fluid Markers of ...... hy in Early Alzheimer Disease.
@en
type
label
Cerebrospinal Fluid Markers of ...... hy in Early Alzheimer Disease.
@ast
Cerebrospinal Fluid Markers of ...... hy in Early Alzheimer Disease.
@en
prefLabel
Cerebrospinal Fluid Markers of ...... hy in Early Alzheimer Disease.
@ast
Cerebrospinal Fluid Markers of ...... hy in Early Alzheimer Disease.
@en
P2093
P2860
P50
P1433
P1476
Cerebrospinal Fluid Markers of ...... hy in Early Alzheimer Disease.
@en
P2093
Denise Head
Jack H Ladenson
Rawan Tarawneh
Samantha Allison
Virginia Buckles
P2860
P304
P356
10.1001/JAMANEUROL.2015.0202
P407
P577
2015-06-01T00:00:00Z